Meeting the Unmet Need: Integrated Pharma Solutions for Improved Patient Care
Join Gillian Molloy, Global VP of Market Access at AscellaHealth, alongside Alexis Moss, AscellaHealth’s EU/UK Director of Business Development, and Jonathan Chapper, CEO of CHAPPER healthcare – AscellaHealth’s newly acquired global pharmaceutical distributor and wholesaler, as they discuss how AscellaHealth and CHAPPER healthcare are addressing the global unmet needs of patients, healthcare providers, and life sciences manufacturers.
This discussion delves into the challenges faced by many life sciences stakeholders, the value of direct patient support and wholesale distribution, and how AscellaHealth’s integrated solutions are transforming access to therapies for patients globally.
About AscellaHealth
Healthcare today is more complex than ever—especially when it comes to therapies for people living with rare and chronic conditions. These high-cost, high-impact treatments account for only a small fraction of prescriptions, but they make up the largest and fastest-growing share of total drug spend. As a result, balancing affordability and quality of care remains a significant challenge.
We’re here to change that.
Because at AscellaHealth, we believe that all patients in need should have the ability to access life-changing therapies.
Our Core Beliefs
At AscellaHealth, patients are not just part of the process—they’re why we do what we do. Every solution we build and every partnership we form is designed with the patient in mind.
Patients First, Always.
Balancing Cost and Care.
Better Stakeholder Outcomes.